The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By

Rights to General, Right Guard and Dry Idea brands

Advised Henkel on its brand divestment program (including the sale of the General, Right Guard and Dry Idea brands)

VEP Healthcare

Advised VEP Healthcare, a leading, physician-owned provider of clinical management services in emergent and inpatient settings in the United States, on its merger with U.S. Acute Care Solutions

Equiniti Group PLC

Advised Siris Capital, a private equity firm focused on the technology sector, on its recommended 180p cash offer for Equiniti Group PLC, a technology-led services and payments specialist

Bacharach, Inc.

Advising MSA Safety Incorporated (NYSE: MSA), on its acquisition of Bacharach, Inc., a leader in gas detection technologies used in the heating, ventilation, air conditioning and refrigeration (HVAC-R) markets, from FFL Partners, a San Francisco based private equity firm

Photon Control

Advising MKS, a global provider of instruments, systems, subsystems and process control solutions, on the acquisition of Photon Control, a Canadian manufacturer of fiber optic measurement solutions used in semiconductor wafer fabrication

International Flavors & Fragrances, Inc.’s Fruit Preparations business

Advised International Flavors & Fragrances on the divestiture of its European-based Fruit Preparation business to Frulact Serviços Partilhados, SA

Whirlpool Corporation

Advised Whirlpool Corporation in its sale of approximately 31% of the outstanding shares of its publicly listed subsidiary in China, Whirlpool China Co. Ltd. through a partial tender offer by Guangdong Galanz Household Appliances Manufacturing Co., Ltd.

MindPath Care Centers

Advised Community Psychiatry, a leading provider of outpatient behavioral health services with a focus on high-quality clinically-driven care, on its acquisition of MindPath Care Centers, deepening its national presence to more than 350 providers across the US

Whinstone Inc. – Subsidiary of Northern Data AG

Advising Northern Data AG, a Germany based developer and operator of high-performance computing (“HPC”) infrastructure solutions, on the sale of its U.S. subsidiary Whinstone Inc., an HPC data center operator based in Rockdale, Texas, to Riot Blockchain Inc., a U.S. based publicly-traded bitcoin miner

Redwire, LLC

Advising Genesis Park Acquisition Corp., a special purpose acquisition company (SPAC) focused on aviation and related end markets, on the acquisition of Redwire, LLC, a pure play leading developer of mission critical solutions for next generation space infrastructure and a portfolio company of AE Industrial Partners, LP

MDLIVE

Advising Cigna on the acquisition of MDLIVE, a virtual care delivery platform, by Evernorth, Cigna’s health services portfolio

Resource Optimization Software Business Area of Net Insight

Advising Net Insight AB, a global leader in media networks, on the divestment of its resource optimization software business area, doing business as “ScheduALL” to Xytech Systems Corporation

Alumisource Corporation

Advised Sims Limited, a global leader in metal recycling and electronics recovery, on the acquisition of certain commercial and operating assets of Alumisource Corporation

The Beachbody Company Group, LLC and Myx Fitness Holdings, LLC

Advising Forest Road Acquisition Corp., a special purpose acquisition company, on the three-way merger with The Beachbody Company Group, LLC and Myx Fitness Holdings, LLC

US Acute Care Solutions

Advising US Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on its recapitalization and buyout of minority partner, Welsh Carson

Biogix, Inc.

Advised Biogix, Inc., a leader in the development, research and distribution of clinically tested menopause and perimenopause supplements in the U.S. under the flagship brand Amberen, on its sale to Alliance Pharma plc

Travel & Transport

Advising Corporate Travel Management on its acquisition of US-based travel management company Travel & Transport and the associated A$375mm equity raise

Windy City Wire Cable & Technology Products

Introduced Diploma PLC, an international group supplying specialized technical products and services, to Windy City Wire Cable & Technology Products, a leading value-add manufacturer and distributor of premium quality, low voltage wire and cable in the US

Surgery Partners’ Anesthesia Services

Advised Surgery Partners, a leading owner and operator of surgical facilities, on the divestiture of its anesthesia services business to NorthStar Anesthesia

340B Link

Advising Omnicell, a leading provider of medication management solutions and adherence tools for health systems and pharmacies, on the acquisition of the 340B Link business from Pharmaceutical Strategies Group (PSG)

Pelco Incorporated

Advised Motorola Solutions, Inc., a global leader in mission-critical communications and analytics, on the acquisition of Pelco Incorporated, a U.S.-based provider of video security solutions

Range Resources Terryville Assets

Advised Castleton Resources, a Houston, TX based, privately held oil and gas operator, on its acquisition of Range Resources’ Terryville Assets. As part of the transaction, Castleton Resources will change its name to “TG Natural Resources LLC” by late March 2021. Range Resources (NYSE: RRC) is a Fort Worth, TX based E&P company with primary operations in the Marcellus Shale formation.

Community Fibre Limited

Advised Warburg Pincus LLC and Deutsche Telekom Capital Partners on the acquisition of a majority stake in CommunityFibre Limited, a leading full fibre network infrastructure platform in UK

Cello Health plc

Advised Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States

Global collaboration agreement with Genmab A/S

Advised AbbVie, Inc, an NYSE-listed global biopharmaceutical company, on a broad collaboration with Genmab A/S, a leading Danish-listed biotechnology company, to jointly develop and commercialise three next-generation bispecific antibody programs